harpoontx.com (HARP) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Harpoon Therapeutics (HARP)

Harpoon Therapeutics (HARP) attracts leading T-cell researchers by offering scientific freedom and RSU packages. This chart from the GURU.Markets terminal allows for a capital assessment based on cash holdings, while the 0.03 value reflects the most recent figure. Revenues are based on partnerships with pharma behemoths. The company is currently integrating its developments into the structure of a global buyer to accelerate the market launch of biologics.

HARP - Cadangan dhuwit perusahaan Harpoon Tx ing rentang 04.07.2022 - 16.03.2024

Rincian analitis perusahaan Harpoon Therapeutics

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Harpoon Therapeutics Inc HARP
Produk merek Harpoon Therapeutics, Inc.

Harpoon Therapeutics (HARP) maintains a strong position in immunotherapy thanks to unique patents for its TriTAC platform. By analyzing the company's cash runway, an investor assesses the volume of highly liquid assets available for operational activities. This metric measures the balance between financial stability and capital efficiency. For a drug developer, this reserve is critical for funding clinical trials between milestone payments. The market views a sufficient cash reserve as a guarantee of a biotech startup's survival.

Pesaing Harpoon Therapeutics (HARP)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|LIMN - Volume dana dhuwit perusahaan|LVTX: Volume dana dhuwit perusahaan|NextCure - Sisa dhuwit perusahaan|LPTX (Leap Therapeutics Inc) - Volume dana dhuwit perusahaan|INTS (Intensity Therapeutics, Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan SNSE|Dana dhuwit perusahaan TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Kineta KA|NexImmune Corporation - Volume dana dhuwit perusahaan|TSBX: Dana dhuwit perusahaan|VCNX: Volume dana dhuwit perusahaan